Effects of Metreleptin in Type 1 Diabetes Mellitus
This study has been terminated.
University of Texas Southwestern Medical Center
Juvenile Diabetes Research Foundation
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Abhimanyu Garg, University of Texas Southwestern Medical Center
First received: December 29, 2010
Last updated: May 2, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||August 2014|
|Primary Completion Date:||January 2013 (Final data collection date for primary outcome measure)|